Martin A J, Landau L I, Phelan P D
Acta Paediatr Scand. 1981 Sep;70(5):683-8. doi: 10.1111/j.1651-2227.1981.tb05768.x.
The effect on growth of asthma has been documented in a prospective study from age 7 to 21 years in a randomly selected group of 342 subjects. These subjects covered the whole spectrum of childhood wheezing. Growth suppression was first noted at 10 years of age in the more severely affected groups and was most marked at 14 years of age. By 21 years of age, all groups had achieved a height and weight not significantly different from control subjects. Growth delay occurred in children with more persistent asthma even if they had never received oral corticosteroid therapy but growth was more delayed in those receiving oral steroids. The effect of steroids was most significant in those with frequent episodic asthma whose asthma alone was probably not sufficiently severe to retard growth.
一项针对342名随机选取受试者的前瞻性研究记录了哮喘对7至21岁人群生长发育的影响。这些受试者涵盖了儿童喘息的所有类型。在病情较重的组中,10岁时首次发现生长抑制,14岁时最为明显。到21岁时,所有组的身高和体重与对照组相比无显著差异。即使从未接受过口服糖皮质激素治疗,持续性哮喘患儿也会出现生长发育延迟,但接受口服糖皮质激素治疗的患儿生长发育延迟更明显。糖皮质激素对频繁发作性哮喘患儿的影响最为显著,这些患儿单独的哮喘病情可能不足以严重到阻碍生长。